ИностранцамНовостиКонтакты
БОЛЬНИЦЫ УНИВЕРСИТЕТАХАДЖЕТТЕПЕ
Запись
RU
  1. Home
  2. Врачи
  3. Проф. д-р Bülent Altun
Проф. д-р Bülent Altun

Проф. д-р

Bülent Altun

Nephrology · Больница для взрослых

Записаться на приём

This page is not yet available in Русский. The Turkish version is shown below.

Обучение

  1. 1990
    Tıp Fakültesi
    Hacettepe Üniversitesi
  2. 1984
    TED Ankara Koleji

Publications

Source: Hacettepe University academic database (AVESİS) · All publications (102) ↗

Articles 63

  1. Diabetes and chronic kidney disease in Turkey (DIAKIT): a cross-sectional cohort studyARICI M., ATEŞ K., Yildiz A., Odabas A. R., TOKGÖZ B., Sezer S., et al.BMC Nephrology, cilt.27, sa.1, 2026 (SCI-Expanded, Scopus)
  2. Reply to the Letter to the Editor: Two Overlooked Issues in Hypertension Management: Risk Thresholds and Obesity Integration Editöre Mektup Yanıtı: Hipertansiyon Tedavisinde Gözden Kaçan İki Konu: Risk Eşikleri ve Obezitenin Tedaviye Dahil EdilmesiÖzin B., ALTUN B., Cesur F. M., ARDIÇ C., ARICI M., Aydoğlu S., et al.Turk Kardiyoloji Dernegi Arsivi, cilt.54, sa.4, ss.365-366, 2026 (ESCI, Scopus, TRDizin)
  3. The Turkish Hypertension Consensus Report 2025 Türk Hipertansiyon Uzlaşı Raporu 2025Özin B., ALTUN B., Cesur M., ARDIÇ C., ARICI M., Aydoğdu S., et al.Turk Kardiyoloji Dernegi Arsivi, cilt.54, sa.3, ss.207-226, 2026 (ESCI, Scopus, TRDizin)
  4. Glycaemic control and complications in haemodialysis patients: The TURK-HEMODIAB StudyGungor O., KORUCU B., Oguz E. G., EREN N., KARACA URAL Z., Dheir H., et al.Clinical Kidney Journal, cilt.19, sa.1, 2026 (SCI-Expanded, Scopus)
  5. Reply to correspondence ‘Gut microbiome–metabolome interplay in nondipper hypertension: pathophysiological insights and clinical perspectives’Ozbek D. A., ALTUN B.Journal of Hypertension, cilt.44, sa.1, ss.231, 2026 (SCI-Expanded, Scopus)
  6. Urinary Biomarker Profiles Define Divergent Pathways in Albuminuric and Non-Albuminuric Diabetic Kidney DiseaseKAYGUSUZ Y., Özbek D. A., ERDUT A., Abanoz R., Korkut M. G., ÖZDEDE M., et al.Kidney Diseases, cilt.12, sa.1, ss.330-345, 2026 (SCI-Expanded, Scopus)
  7. Interplay of gut microbiome and metabolome in various blood pressure phenotypes based on ambulatory BP monitoring reveal new insights in nondipper patientsOzbek D. A., Koc N. S., Inal N., ERDOĞAN KABLAN S., KAYGUSUZ Y., KARAHAN S., et al.JOURNAL OF HYPERTENSION, cilt.43, sa.9, ss.1539-1553, 2025 (SCI-Expanded, Scopus)
  8. A Case of Axillary Arterial Aneurysm Due to Group D Non- Typhoidal SalmonellaKaygusuz B., GİRGİN S., İNKAYA A. Ç., ALTUN B.TURKISH JOURNAL OF NEPHROLOGY, cilt.34, sa.1, ss.63-64, 2025 (ESCI, Scopus, TRDizin)
  9. Allogeneic bone marrow mesenchymal stem cell-derived exosomes alleviate human hypoxic AKI-on-a-Chip within a tight treatment windowÇam S. B., Çiftci E., Gürbüz N., ALTUN B., KORKUSUZ P.Stem Cell Research and Therapy, cilt.15, sa.1, 2024 (SCI-Expanded, Scopus)
  10. Chronic Kidney Disease Risk in Living Kidney Transplant Donors: A Long-Term Follow-Up StudyHABERAL G., YILDIRIM T., YILMAZ Ş. R., ALTUN B., AKI F. T., ERDEM Y., et al.Nephron, cilt.148, sa.3, ss.171-178, 2024 (SCI-Expanded, Scopus)
  11. A comparative urinary proteomic and metabolomic analysis between renal aa amyloidosis and membranous nephropathy with clinicopathologic correlationsÖZBEK D. A., Koc S. C., Kucuk N. E. O., Kablan S., YET İ., ÜNER M., et al.JOURNAL OF PROTEOMICS, cilt.293, 2024 (SCI-Expanded, Scopus)
  12. The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trialsARICI M., ALTUN B., Araz M., Atmaca A., DEMİR T., Ecder T., et al.FRONTIERS IN MEDICINE, cilt.11, 2024 (SCI-Expanded, Scopus)
  13. Regional expert opinion: Management of heart failure with preserved ejection fraction in the Middle East, North Africa and TurkeyAbdelhamid M., Al Ghalayini K., Al-Humood K., ALTUN B., Arafah M., Bader F., et al.ESC Heart Failure, cilt.10, sa.5, ss.2773-2787, 2023 (SCI-Expanded, Scopus)
  14. A standard hemodialysis prescription to prevent osmotic demyelination in hyponatremic patients requiring dialysisKOÇ N. S., YILDIRIM T., GİRGİN S., ÖNAL C., TAHILLIOĞLU Y., Yilmaz R., et al.THERAPEUTIC APHERESIS AND DIALYSIS, cilt.26, sa.6, ss.1182-1186, 2022 (SCI-Expanded, Scopus)
  15. Effects of Interdialytic Weight Gain and Salt Intake on Serum Vascular Endothelial Growth Factor-C (VEGF-C) Levels in Hemodialysis PatientsTurkmen E., Altindal M., YILDIRIM T., Yilmaz R., ARICI M., ERDEM Y., et al.TURKISH JOURNAL OF NEPHROLOGY, cilt.31, sa.2, ss.171-176, 2022 (ESCI, Scopus, TRDizin)
  16. Evaluation of renal fibrosis in various causes of glomerulonephritis by MR elastography: a clinicopathologic comparative analysisGÜVEN A. T., İDİLMAN İ. S., Cebrayilov C., ÖNAL C., ÜZERK KİBAR M., Saglam A., et al.ABDOMINAL RADIOLOGY, cilt.47, sa.1, ss.288-296, 2022 (SCI-Expanded, Scopus)
  17. The effect of hypertension and antihypertensive therapies on the course of COVID-19 infection: Turkish national health system dataÖZKAN G., ULUSOY Ş., ERDEM Y., ALTUN B., Yilmaz R., Ata N., et al.CLINICAL AND EXPERIMENTAL HYPERTENSION, cilt.44, ss.502-506, 2022 (SCI-Expanded, Scopus)
  18. The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy: the data from TSN-GOLD working groupTURGUTALP K., Cebeci E., Turkmen A., DERİCİ Ü., SEYAHİ N., EREN N., et al.BMC NEPHROLOGY, cilt.22, sa.1, 2021 (SCI-Expanded, Scopus)
  19. Efficacy and Safety of Switching to Azathioprine for Mycophenolate-Induced Diarrhea in Renal Transplant RecipientsSEKMEK S., YILDIRIM T., KOÇ N. S., ÖNAL C., Jabrayilov J., Yilmaz R., et al.TRANSPLANTATION PROCEEDINGS, cilt.53, sa.6, ss.1951-1956, 2021 (SCI-Expanded, Scopus)
  20. EFFICACY AND SAFETY OF SWITCHING TO AZATHIOPRINE FOR MYCOPHENOLATE INDUCED DIARRHEA IN RENAL TRANSPLANT RECIPIENTSSEKMEK S., YILDIRIM T., KOÇ N. S., ÖNAL C., Jabrayilov J., YILMAZ Ş. R., et al.NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.36, 2021 (SCI-Expanded, Scopus)
  21. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working GroupSumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.53, sa.5, ss.945-954, 2021 (SCI-Expanded, Scopus)
  22. Social Responsibility Programs may Strengthen the Medical Students’ Role to Fight against COVID-19 PandemicASLAN D., DEMİRÖREN M., ATILGAN B., GÜLER S., KAPLAN Ü., ATİLLA P., et al.Acta Medica, cilt.52, sa.1, 2021 (TRDizin)
  23. The Weekend Effect in Chronic Hemodialysis Patients, a Single Center ExperienceYILDIRIM T., ŞENER Y. Z., BÖLEK E. Ç., Yilmaz R., ARICI M., ALTUN B., et al.IRANIAN JOURNAL OF KIDNEY DISEASES, cilt.14, sa.3, ss.219-223, 2020 (SCI-Expanded, Scopus)
  24. 2019 Turkish Hypertension Consensus ReportAydogdu S., Guler K., BAYRAM F., ALTUN B., DERİCİ Ü., ABACI A., et al.TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.47, sa.6, ss.535-546, 2019 (ESCI, Scopus, TRDizin)
  25. Hemodialysis Experience of a Large Group of Syrian Refugees in Turkey: All Patients Deserve Effective TreatmentGÜRSU M., ARICI M., ATEŞ K., KAZANCIOĞLU R., Yavas P. G., Ozturk M., et al.KIDNEY & BLOOD PRESSURE RESEARCH, cilt.44, sa.1, ss.43-51, 2019 (SCI-Expanded, Scopus)
  26. Role of Local Renin Angiotensin System Activation on Blood Pressure and Residual Renal Function in Peritoneal Dialysis PatientsYILDIRIM T., Yilmaz R., Azak A., Altindal M., TÜRKMEN E., ARICI M., et al.TURKISH JOURNAL OF NEPHROLOGY, cilt.28, sa.1, ss.17-23, 2019 (ESCI, Scopus, TRDizin)
  27. Data on prevalence of hypertension and blood pressure in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factorsKilickap M., Barcin C., GÖKSÜLÜK H., Karaaslan D., ÖZER N., Kayikcioglu M., et al.TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.46, sa.7, ss.525-545, 2018 (ESCI, Scopus, TRDizin)
  28. HFE gene mutation is a risk factor for tissue iron accumulation in hemodialysis patientsTÜRKMEN E., YILDIRIM T., Yilmaz R., HAZIROLAN T., Eldem G., YILMAZ E., et al.HEMODIALYSIS INTERNATIONAL, cilt.21, sa.3, ss.359-366, 2017 (SCI-Expanded, Scopus)
  29. The relationship between dietary salt intake and ambulatory blood pressure variability in non-diabetic hypertensive patientsOzkayar N., Dede F., Ates I., Akyel F., Yildirim T., ALTUN B.NEFROLOGIA, cilt.36, sa.6, ss.694-700, 2016 (SCI-Expanded, Scopus)
  30. Prevalence of Chronic Kidney Disease in Turkish Adults With Obesity and Metabolic Syndrome: A Post Hoc Analysis from Chronic Renal Disease in Turkey StudyArinsoy T., Deger S. M., ATEŞ K., ALTUN B., Ecder T., ÇAMSARI T., et al.JOURNAL OF RENAL NUTRITION, cilt.26, sa.6, ss.373-379, 2016 (SCI-Expanded, Scopus)
  31. Kidney transplantation for end-stage renal disease secondary to familial Mediterranean feverAltindal M., TÜRKMEN E., YILDIRIM T., Yilmaz R., AKI F. T., ARICI M., et al.CLINICAL TRANSPLANTATION, cilt.30, sa.7, ss.787-790, 2016 (SCI-Expanded, Scopus)
  32. Turkish hypertension consensus reportARICI M., BİRDANE A., Guler K., Yildiz B. O., ALTUN B., ERTÜRK Ş., et al.TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.43, sa.4, ss.402-409, 2015 (ESCI, Scopus, TRDizin)
  33. Endothelial Dysfunction in Renal Transplant Recipients: Role of Vitamin D and Fibroblast Growth Factor-23YILDIRIM T., YILMAZ R., ALTİNDAL M., TURKMEN E., ARICI M., ALTUN B., et al.TRANSPLANTATION PROCEEDINGS, cilt.47, sa.2, ss.343-347, 2015 (SCI-Expanded, Scopus)
  34. Safety of Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with AA AmyloidosisAltindal M., YILDIRIM T., Turkmen E., Unal M., Boga I., Yilmaz R., et al.NEPHRON, cilt.131, sa.1, ss.17-22, 2015 (SCI-Expanded, Scopus, TRDizin)
  35. Demographic and clinical characteristics of primary glomerular diseases in TurkeyOzturk S., Sumnu A., SEYAHİ N., GÜLLÜLÜ M., Sipahioglu M., Artan S., et al.INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.46, sa.12, ss.2347-2355, 2014 (SCI-Expanded, Scopus)
  36. Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemiaDuman N., UYANIK A., Unsal A., Sezer S., ÇAMSARI T., Cirit M., et al.CLINICAL KIDNEY JOURNAL, cilt.7, sa.5, 2014 (ESCI, Scopus)
  37. RELATIONSHIP BETWEEN VITAMIN D LEVELS AND DEPRESSIVE SYMPTOMS IN RENAL TRANSPLANT RECIPIENTSOzkayar N., ALTUN B., Ulusoy S., YILDIRIM T., HALİL M. G., Yilmaz R., et al.INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, cilt.47, sa.2, ss.141-151, 2014 (SCI-Expanded, SSCI, Scopus)
  38. Blood pressure measurements, blood pressure variability and endothelial function in renal transplant recipientsOzkayar N., ALTUN B., YILDIRIM T., Yilmaz R., Dede F., Arik G., et al.CLINICAL AND EXPERIMENTAL HYPERTENSION, cilt.36, sa.6, ss.392-397, 2014 (SCI-Expanded, Scopus)
  39. An Uninvestigated Risk Factor for Contrast-Induced Nephropathy in Chronic Kidney Disease: ProteinuriaPiskinpasa S., ALTUN B., AKOĞLU H., YILDIRIM T., AĞBAHT K., Yilmaz R., et al.RENAL FAILURE, cilt.35, sa.1, ss.62-65, 2013 (SCI-Expanded, Scopus)
  40. Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patientsYILMAZ R., AKOGLU H., ALTUN B., YILDIRIM T., ARICI M., ERDEM Y.EUROPEAN JOURNAL OF CLINICAL NUTRITION, cilt.66, sa.11, ss.1214-1218, 2012 (SCI-Expanded, Scopus)
  41. The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patientsKutlugun A. A., ALTUN B., Aktan U., TÜRKMEN E., Altindal M., YILDIRIM T., et al.AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, cilt.19, sa.1, ss.28-32, 2012 (SCI-Expanded, Scopus)
  42. Major Barriers against Renin-Angiotensin-Aldosterone System Blocker Use in Chronic Kidney Disease Stages 3-5 in Clinical Practice: A Safety Concern?YILDIRIM T., ARICI M., Piskinpasa S., Aybal-Kutlugun A., Yilmaz R., ALTUN B., et al.RENAL FAILURE, cilt.34, sa.9, ss.1095-1099, 2012 (SCI-Expanded, Scopus)
  43. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?Kutlugun A. A., ALTUN B., BÜYÜKAŞIK Y., AKI F. T., TÜRKMEN E., Altindal M., et al.TRANSPLANT INTERNATIONAL, cilt.25, sa.1, ss.13-18, 2012 (SCI-Expanded, Scopus)
  44. Supplementary Ultrafiltration May Improve Inflammation and Cardiac Dysfunction in Patients with High Interdialytic Weight GainYilmaz R., ARICI M., YILDIRIM T., Sahiner L., AYTEMİR K., ALTUN B., et al.BLOOD PURIFICATION, cilt.34, sa.1, ss.67-74, 2012 (SCI-Expanded, Scopus)
  45. Postural Epigastric Pain: A Challenging Symptom for Cytomegalovirus (CMV) GastritisTapan U., Kutlugun A. A., ARICI M., ALTUN B.RENAL FAILURE, cilt.34, sa.2, ss.235-236, 2012 (SCI-Expanded, Scopus)
  46. Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury OutcomesALTUN B., Yilmaz R., Aki T., Akoglu H., Zeybek D., Piskinpasa S., et al.AMERICAN JOURNAL OF NEPHROLOGY, cilt.35, sa.6, ss.531-539, 2012 (SCI-Expanded, Scopus)
  47. Prevalence, Awareness, Treatment and Control of Hypertension in Adults with Chronic Kidney Disease in Turkey: Results from the CREDIT StudyALTUN B., SÜLEYMANLAR G., UTAŞ C., Arinsoy T., ATEŞ K., Ecder T., et al.KIDNEY & BLOOD PRESSURE RESEARCH, cilt.36, sa.1, ss.36-46, 2012 (SCI-Expanded, Scopus)
  48. A population-based survey of Chronic REnal Disease In Turkey-the CREDIT studySÜLEYMANLAR G., UTAŞ C., Arinsoy T., ATEŞ K., ALTUN B., Altiparmak M. R., et al.NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.26, sa.6, ss.1862-1871, 2011 (SCI-Expanded, Scopus)
  49. The relationship between hypertension and salt intake in Turkish population: SALTURK studyErdem Y., ARICI M., Altun B., Turgan C., Sindel S., Erbay B., et al.BLOOD PRESSURE, cilt.19, sa.5, ss.313-318, 2010 (SCI-Expanded, Scopus)
  50. Hypertension incidence in Turkey (HinT): a population-based studyARICI M., Turgan C., ALTUN B., Sindel S., Erbay B., DERİCİ Ü., et al.JOURNAL OF HYPERTENSION, cilt.28, sa.2, ss.240-244, 2010 (SCI-Expanded, Scopus)
  51. Impact of cytokine genotype on cardiovascular surrogate markers in hemodialysis patientsYilmaz R., ALTUN B., ÖZER N., HAZIROLAN T., Turgan C.RENAL FAILURE, cilt.32, sa.7, ss.806-816, 2010 (SCI-Expanded, Scopus)
  52. Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patientsYilmaz R., ALTUN B., Kahraman S., ÖZER N., AKINCI D., Turgan C.RENAL FAILURE, cilt.32, sa.8, ss.903-912, 2010 (SCI-Expanded, Scopus)
  53. Serum Stem Cell Factor Level in Renal Transplant Recipients With Posttransplant ErythrocytosisKiykim A. A., Genctoy G., Horoz M., Tiftik N. E., Gok E., ALTUN B., et al.ARTIFICIAL ORGANS, cilt.33, sa.12, ss.1086-1090, 2009 (SCI-Expanded, Scopus)
  54. Association Among Serum Fetuin-A Level, Coronary Artery Calcification, and Bone Mineral Densitometry in Maintenance Hemodialysis PatientsKirkpantur A., ALTUN B., HAZIROLAN T., AKATA D., ARICI M., Kirazli S., et al.ARTIFICIAL ORGANS, cilt.33, sa.10, ss.844-854, 2009 (SCI-Expanded, Scopus)
  55. Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatmentOnal I. K., ALTUN B., Onal E. D., Kirkpantur A., ÖZ Ş. G., Turgan C.EUROPEAN JOURNAL OF INTERNAL MEDICINE, cilt.20, sa.4, ss.369-372, 2009 (SCI-Expanded, Scopus)
  56. Inflation of diagnostic tests in hypertensive young adults: a need for diagnostic guideline?Kirkpantur A., ARICI M., ALTUN B., Turgan C.CENTRAL EUROPEAN JOURNAL OF MEDICINE, cilt.4, sa.2, ss.233-240, 2009 (SCI-Expanded, Scopus)
  57. A Hypertensive Patient With Polycystic Horseshoe KidneyKirkpantur A., ALTUN B., Yilmaz M. I., Yenicesu M.TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.18, sa.2, ss.87-89, 2009 (ESCI, Scopus, TRDizin)
  58. Concomitant amyloidosis, renal papillary carcinoma and ipsilateral pelvicalyceal urothelial carcinoma in a patient with familial Mediterranean feverKirkpantur A., BAYDAR D., ALTUN B., KARÇAALTINCABA M., AKI F. T., Yuksel S., et al.AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, cilt.16, sa.1, ss.54-59, 2009 (SCI-Expanded, Scopus)
  59. The interleukin-10 promoter genotype predicts diastolic dysfunction in maintenance hemodialysis patientsKirkpantur A., Kahraman S., Genctoy G., ALTUN B., Abali G., ARICI M., et al.HEMODIALYSIS INTERNATIONAL, cilt.12, sa.3, ss.352-361, 2008 (SCI-Expanded, Scopus)
  60. Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patientsKirkpantur A., ARICI M., ALTUN B., Yilmaz M. I., Cil B., AKI F. T., et al.BLOOD PURIFICATION, cilt.26, sa.4, ss.322-332, 2008 (SCI-Expanded, Scopus)

All 63 on AVESİS →

Conference papers 39

  1. Exploring the interplay between gut microbiome, fecal metabolomics and ambulatory blood pressure in white-coat hypertensive patientsÖZBEK D. A., KOÇ N. S., nal N. e., ERDOĞAN KABLAN S., KAYGUSUZ Y., KARAHAN S., et al.61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)
  2. Inadequate diagnostic investigations and low treatment rates in CKD anemia: an inertia that can only change with long-term follow-upKurak C. d. K., Karlik S., HAYRAN K. M., HABERAL G., ERDUT A., YETER H. H., et al.61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)
  3. Membranous nephropathy has higher all-cause mortality rate in comparison to focal segmental glomerulosclerosis and IgA nephropathy: a long-term studyZiya Y. S., Jabrayi'lov J., ÇELEBİ G., HABERAL G., ERDUT A., YETER H. H., et al.61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)
  4. IMPACT OF HYPERTENSION ON OUTCOMES IN PATIENTS WITH MEMBRANOUS NEPHROPATHYŞENER Y. Z., Jabrayilov J., ÇELEBİ G., HABERAL G., ERDUT A., Ayhan A. S., et al.33rd European Meeting on Hypertension and Cardiovascular Renal Protection (ESH), Berlin, Almanya, 31 Mayıs - 03 Haziran 2024, (Özet Bildiri)
  5. EPIDEMIOLOGICAL AND CLINICAL CHARACTERSTICS OF IGA NEPHROPATHY PATIENTS IN TURKEY: TSN-GOLD WORKING GROUPEREN N., GÜRSU M., Cebeci E., Turkmen A., YETER H. H., SEYAHİ N., et al.57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.749, (Özet Bildiri)
  6. IS THE SEVERITY OF GLOMERULAR IGG STAINING IN PATIENT WITH IGA NEPHROPATHY USEFUL FOR PREDICTING POOR RENAL PROGNOSIS? THE DATA FROM TSN-GOLD WORKING GROUPTURGUTALP K., Cebeci E., Turkmen A., DERİCİ Ü., SEYAHİ N., EREN N., et al.57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.800, (Özet Bildiri)
  7. CHARACTERISTICS OF PRIMARY GLOMERULAR DISEASE PATIENTS WITH HEMATURIA IN TURKEY: THE DATA FROM TSN-GOLD WORKING GROUPSumnu A., TÜRKMEN K., Cebeci E., Turkmen A., EREN N., Seyahi N., et al.57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.757, (Özet Bildiri)
  8. THE WEEKEND EFFECT IN CHRONIC HEMODIALYSIS PATIENTS: A SINGLE CENTER EXPERIENCEYILDIRIM T., ŞENER Y. Z., BÖLEK E. Ç., Yilmaz R., ARICI M., ALTUN B., et al.56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, Macaristan, 13 - 16 Haziran 2019, cilt.34, ss.573, (Özet Bildiri)
  9. Program Amaç ve Çıktılarını GüncellemedePaydaş Katılımı: Hacettepe Tıp FakültesiDeneyimiDEMİRÖREN M., ÇİFTÇİ ATILGAN S. B., TAŞDELEN TEKER G., TURAN S., ELÇİN M., ATİLLA P., et al.X. Ulusal Tıp Eğitimi Kongresi, Türkiye, 9 - 12 Mayıs 2018, (Özet Bildiri)
  10. Tıp Fakültesine Başlarken: Hacettepe Üniversitesi Tıp Fakültesi Hekimliği Öğreniyorum ProgramıTURAN S., DEMİRÖREN M., TAŞDELEN TEKER G., ÇİFTÇİ ATILGAN S. B., ABAY Ş. E., SEZER B., et al.Tıp Eğitimini Geliştirme Derneği UTEK’18 X. Ulusal Tıp Eğitimi Kongresi, İzmir, Türkiye, 9 - 12 Mayıs 2018, ss.45-46, (Özet Bildiri)
  11. Urinary Type III Procollagen Is Associated With Chronic AllograftDysfunction and Predicts Graft SurvivalYILMAZ Ş. R., YILDIRIM T., BAYDAR D., ALTUN B., ERDEM Y.2017 American Transplant Congress, 29 Nisan - 03 Mayıs 2017, (Özet Bildiri)
  12. Mesenchymal stem cells regulate the hematopoietic stem cell mobilization through the endocannabinoidsKOSE S., KOPRU Z. C., KARAOSMANOĞLU B., Taskiran E. Z., Kaya F. A., NEMUTLU E., et al.Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, İtalya, 18 - 21 Ekim 2016, cilt.27, (Özet Bildiri)
  13. DİRENÇLİ MEMBRANÖZ GLOMERÜLONEFRİTTE RİTUKSİMAB KULLANIMI TEK MERKEZ DENEYİMİŞENER Y. Z., YILDIRIM T., YILMAZ Ş. R., ARICI M., ALTUN B., ERDEM Y.33. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Türkiye, 19 - 23 Ekim 2016
  14. Atipik prezentasyonlu bir subakut endokardit olgusuÇALIK BAŞARAN N., ASLAN A. T., ÖZIŞIK L., ALTUN B.17. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 14 - 18 Ekim 2015, ss.165
  15. FP831PROGNOSTIC ROLE OF SERUM PROCOLLAGEN LEVELS ON GRAFT SURVIVAL IN RENAL TRANSPLANT RECIPIENTSYILDIRIM T., YILMAZ Ş. R., BAYDAR D., ARICI M., ALTUN B., ERDEM Y.52nd ERA-EDTA CONGRESS LONDON 2015, 28 - 31 Mayıs 2015
  16. SP799EFFECT OF RENAL TRANSPLANTATION ON RENALASE LEVELS IN DONORS AND RECIPIENTSABUDALAL A., YILDIRIM T., YILMAZ Ş. R., ARICI M., ALTUN B., ERDEM Y.52 rd ERA-EDTA CONGRESS LONDON 2015, 28 - 31 Mayıs 2015
  17. EFFECT OF RENAL TRANSPLANTATION ON RENALASE LEVELS IN DONORS AND RECIPIENTSAbudalal A., YILDIRIM T., Yilmaz R., ARICI M., ALTUN B., ERDEM Y.52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London, Kanada, 28 - 31 Mayıs 2015, cilt.30, (Özet Bildiri)
  18. PROGNOSTIC ROLE OF SERUM PROCOLLAGEN LEVELS ON GRAFT SURVIVAL IN RENALTRANSPLANT RECIPIENTSYILDIRIM T., Yilmaz R., BAYDAR D., ARICI M., ALTUN B., ERDEM Y.52nd Congress of the European-Renal-Association-European-Dialysis-and-Transplant-Assocation, London, Kanada, 28 - 31 Mayıs 2015, cilt.30, (Özet Bildiri)
  19. EFFECT OF VITAMIN D REPLACEMENT ON ENDOTHELIAL FUNCTIONS IN RENAL TRANSPLANT RECIPIENTSYILDIRIM T., Yilmaz R., TÜRKMEN E., Altindal M., ARICI M., ALTUN B., et al.51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA), Amsterdam, Hollanda, 31 Mayıs - 03 Haziran 2014, cilt.29, ss.322, (Özet Bildiri)
  20. LOCAL RENIN ANGIOTENSIN SYSTEM ACTIVATION IN PREECLAMPSIAYilmaz Z., YILDIRIM T., Yilmaz R., Aybal-Kutlugun A., ALTUN B., Kucukozkan T., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.90-91, (Özet Bildiri)
  21. BLOOD PRESSURE AND RESIDUAL RENAL FUNCTION IN PERITONEAL DIALYSIS: ROLE OF LOCAL RENIN ANGIOTENSIN SYSTEM ACTIVATIONYILDIRIM T., Yilmaz R., Azak A., Altindal M., TÜRKMEN E., ARICI M., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.223-224, (Özet Bildiri)
  22. RELATIONSHIP BETWEEN BLOOD PRESSURE VALUES, BLOOD PRESSURE VARIABILITY AND ENDOTHELIAL FUNCTIONS IN RENAL TRANSPLANT RECIPIENTSOzkayar N., ALTUN B., YILDIRIM T., Yilmaz R., Dede F., HAYRAN K. M., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.85-86, (Özet Bildiri)
  23. ENDOTHELIAL DYSFUNCTION IN RENAL TRANSPLANT RECIPIENTS: ROLE OF VITAMIN D AND FIBROBLAST GROWTH FACTOR-23YILDIRIM T., Yilmaz R., Altindal M., TÜRKMEN E., ARICI M., ALTUN B., et al.50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress, İstanbul, Türkiye, 18 - 21 Mayıs 2013, cilt.28, ss.275, (Özet Bildiri)
  24. Sleep duration, coronary artery calcification and inflammation in maintenance hemodialysis patientsKirkpantur A., Yilmaz R., Emmungil H., HAZIROLAN T., ARICI M., ALTUN B., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.331, (Özet Bildiri)
  25. Proton pump inhibitor use and bone mineral densitometry in maintenance hemodialysis patientsKirkpantur A., Yilmaz R., AKOĞLU H., ARICI M., ALTUN B., ERDEM Y., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.174-175, (Özet Bildiri)
  26. Ultrasonographic lower limb enthesitis score predicts coronary artery calcification in maintenance hemodialysis patientsKirkpantur A., Yilmaz R., Kerimoglu U., HAZIROLAN T., ARICI M., ALTUN B., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.340, (Özet Bildiri)
  27. Persistent elevation of inflammation marker C-reactive protein is associated with atherosclerosis and left ventricular hypertrophy in chronic hemodialysis patients: 2 year follow-up studyYilmaz R., Kirkpantur A., Deniz A., Ciftci O., ALTUN B., ARICI M., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.312, (Özet Bildiri)
  28. Utility of C2 monitoring in prediction of diastolic dysfunction in renal transplant recipientsKirkpantur A., Yilmaz R., Abali G., ARICI M., ALTUN B., AKI F. T., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.387, (Özet Bildiri)
  29. The utility of the Doppler ultrasound parameter, resistive index, in renal transplant histopathologyKirkpantur A., Yilmaz R., BAYDAR D., Aki T., ARICI M., ALTUN B., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.272-273, (Özet Bildiri)
  30. The role of inflammatory activity and atherosclerosis on thrombosed arterio-venous fistula for hemodialysis accessYilmaz R., Kirkpantur A., ALTUN B., AKOĞLU H., Aki T., ERDEM Y., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.159, (Özet Bildiri)
  31. The association between coronary artery calcification, arteriovenous fistula thrombosis and bone mineral density in maintenance hemodialysis patients: Is serum fetuin-A level the missing link?Kirkpantur A., ALTUN B., Yilmaz R., HAZIROLAN T., Aki T., ARICI M., et al.44th ERA-EDTA Congress, Barcelona, İspanya, 22 - 24 Haziran 2007, cilt.22, ss.327, (Özet Bildiri)
  32. Serum lipid profile and arteriovenous fistula thrombosis risk: A retrospective study on reverse epidemiologyKirkpantur A., Yilmaz R., Aki T., Bakkaloglu M., Altun B., Arici M., et al.43rd ERA-EDTA Congress, Glasgow, Birleşik Krallık, 15 - 18 Temmuz 2006, cilt.21, ss.467, (Özet Bildiri)
  33. Cystatin C is a novel marker for estimating GFR: Is it purely indicator in renal transplant recipients?Yilmaz R., Kirkpantur A., Akoglu H., Arici M., Altun B., Erdem Y., et al.43rd ERA-EDTA Congress, Glasgow, Birleşik Krallık, 15 - 18 Temmuz 2006, cilt.21, ss.305, (Özet Bildiri)
  34. Serum matrix metalloproteinase 2, 9 and tissue inhibitor of metalloproteinase 1 levels in mild hypertensive patients: Effect of blood pressure treatmentOnal I. K., Altun B., Yilmaz R., Kirkpantur A., Arici M., Oz S. G., et al.43rd ERA-EDTA Congress, Glasgow, Birleşik Krallık, 15 - 18 Temmuz 2006, cilt.21, ss.303, (Özet Bildiri)
  35. Impact of cytokine gene polymorphisms on cardiovascular risk in renal transplant recipients: One-year follow-up studyYilmaz R., Altun B., Kirkpantur A., Sahiner L., Arici M., Erdem Y., et al.43rd ERA-EDTA Congress, Glasgow, Birleşik Krallık, 15 - 18 Temmuz 2006, cilt.21, ss.516, (Özet Bildiri)
  36. IS THERE AN ASSOCİATİON BETWEEN HYPOALBUMİNEMİA OF VARİOUS ETİOLOGİES ON CELLULAR ADHESİON MOLECULESSERKAN K., ARICI M., ALTUN B., ÇALIK BAŞARAN N., ERDEM Y., YASAVUL Ü., et al.XXXIX. CONGRESS OF THE EUROPEAN RENAL ASSOCİATİON, EUROPEAN DİALYSİS AND TRANSPLANT ASSOCİATİON, KOPENHAG, Danimarka, 14 - 17 Temmuz 2002, cilt.17, (Özet Bildiri)
  37. Evaluation of Working Conditions and Occupational Accidents in woodworking Workplaces (Ankara, Siteler Region, 2000)Koral Ö. I., ALTUN B., KURT M., Kireççi A., ÇAKIR B., BAĞCI BOSI A. T., et al.International Public Health Congress "Health 21 in Action", İstanbul, Türkiye, 08 Ekim 2000, (Özet Bildiri)
  38. CLINICOPATHOLOGIC CORRELATIONS OF URINARY PROTEOMIC AND METABOLOMIC ANALYSIS IN PATIENTS WITH RENAL AA AMYLOIDOSIS AND MEMBRANOUS NEPHROPATHYOzbek D. A., Koc S., YET İ., Kucuk N. E., ERDOĞAN KABLAN S., ÜNER M., et al.
  39. A New Program Experience “Becoming Physician and Social Responsibility (BPSR)”ÇİFTÇİ ATILGAN S. B., DEMİRÖREN M., ATİLLA P., ALTUN B.

Контакты

Department
Nephrology, Больница для взрослых

Последнее обновление: